Beaumont Asset Management L.L.C. Invests $641,000 in Danaher Corporation $DHR

Beaumont Asset Management L.L.C. acquired a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,800 shares of the conglomerate’s stock, valued at approximately $641,000.

A number of other institutional investors have also made changes to their positions in the stock. JPL Wealth Management LLC bought a new stake in Danaher during the third quarter worth approximately $25,000. WFA of San Diego LLC acquired a new position in Danaher during the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Danaher in the third quarter valued at approximately $27,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the second quarter worth $27,000. Finally, TruNorth Capital Management LLC acquired a new stake in shares of Danaher in the third quarter worth $28,000. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Jefferies Financial Group boosted their target price on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Argus set a $265.00 price objective on Danaher in a research note on Wednesday, January 14th. Finally, The Goldman Sachs Group cut their price objective on Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 29th. Nineteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $253.55.

Check Out Our Latest Report on Danaher

Danaher Trading Up 0.0%

Shares of DHR stock opened at $191.18 on Monday. The firm has a market capitalization of $135.30 billion, a P/E ratio of 37.93, a price-to-earnings-growth ratio of 2.59 and a beta of 0.95. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80. The firm’s fifty day simple moving average is $204.49 and its 200 day simple moving average is $214.63. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.14 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be paid a $0.40 dividend. The ex-dividend date is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio is 31.75%.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.